secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2026-05-12T20:16:15+00:00
Accession:  0001213900-26-055085
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical Q1 2026 revenue $1.4M (+90% YoY), gross margin expands to 68.5%
-----------------------------------------------------------------------------

- Revenue $1.4M, up ~90% YoY from $0.7M; gross profit $0.9M, up ~193% YoY.
- Gross margin improved 24 percentage points to 68.5% from 44.5% in Q1 2025.
- Net loss $3.5M ($0.31/share) vs $3.6M ($1.01/share); cash $4.6M at quarter end.
- Closed $4.3M senior convertible note private placement to fund commercial expansion and development.
- Post-quarter: opened Center of Excellence in Tampa, FL and expanded Eastern region sales leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026055085/0001213900-26-055085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026055085/ea0290384-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-055085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer